The Biden administration released revised guidance for the Medicare drug price negotiation program late last week in response to the mounting lawsuits against the policy required by the Inflation Reduction Act (IRA) of 2022.
Drugmakers Merck and Bristol Myers Squibb, as well as industry representatives like the U.S. Chamber of...
Pharmaceutical industry advocacy organizations including the Pharmaceutical Research and Manufacturers of America (PhRMA) and a third drug manufacturer have sued the federal government over the provision of the Inflation Reduction Act (IRA) that allowed for Medicare drug price negotiation for select pharmaceuticals.
Pharmaceutical...
